Human Bone Marrow Activates the Akt Pathway in Metastatic Prostate Cells through Transactivation of the α-Platelet–Derived Growth Factor Receptor

作者: Nathan G. Dolloff , Mike R. Russell , Nick Loizos , Alessandro Fatatis

DOI: 10.1158/0008-5472.CAN-06-2593

关键词:

摘要: The factors regulating the bone tropism of disseminated prostate cancer cells are still vaguely defined. We report that metastasize to skeleton respond human marrow with a robust stimulation phosphatidylinositol 3-kinase/Akt pathway, whereas lack bone-metastatic potential negligibly. majority this Akt activation is dependent on α-platelet–derived growth factor receptor (α-PDGFR) signaling, which was shown using small-molecule inhibitor PDGFR signaling AG1296. Low concentrations PDGF-AA and PDGF-BB found in aspirates, were detected by ELISA, do not account for high levels α-PDGFR signaling. Additionally, neutralizing PDGF binding α-PDGFR–specific antibody (IMC-3G3) failed produce significant inhibition marrow–induced activation. However, inhibitory effect IMC-3G3 rivaled AG1296 when incubation done under conditions stimulated internalization. conclude activated multiple soluble contained within marrow, addition its natural ligands, transactivation localization plasma membrane. Therefore, expression may provide select phenotypes advantage microenvironment. [Cancer Res 2007;67(2):555–62]

参考文章(31)
M E Kaighn, Y Ohnuki, K S Narayan, L W Jones, J F Lechner, Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Investigative urology. ,vol. 17, pp. 16- 23 ,(1979)
Annette B. Rice, Cindy R. Moomaw, Daniel L. Morgan, James C. Bonner, Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats. American Journal of Pathology. ,vol. 155, pp. 213- 221 ,(1999) , 10.1016/S0002-9440(10)65115-2
Dehong Yang, Jianting Chen, Zongsen Jing, Dadi Jin, PLATELET-DERIVED GROWTH FACTOR (PDGF)-AA: A SELF-IMPOSED CYTOKINE IN THE PROLIFERATION OF HUMAN FETAL OSTEOBLASTS Cytokine. ,vol. 12, pp. 1271- 1274 ,(2000) , 10.1006/CYTO.2000.0707
Oriol Casanovas, Daniel J. Hicklin, Gabriele Bergers, Douglas Hanahan, Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors Cancer Cell. ,vol. 8, pp. 299- 309 ,(2005) , 10.1016/J.CCR.2005.09.005
Henrik Daub, F. Ulrich Weiss, Christian Wallasch, Axel Ullrich, Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors Nature. ,vol. 379, pp. 557- 560 ,(1996) , 10.1038/379557A0
Stephen Paget, THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. The Lancet. ,vol. 133, pp. 571- 573 ,(1889) , 10.1016/S0140-6736(00)49915-0
A. Herrlich, H. Daub, A. Knebel, P. Herrlich, A. Ullrich, G. Schultz, T. Gudermann, Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells Proceedings of the National Academy of Sciences of the United States of America. ,vol. 95, pp. 8985- 8990 ,(1998) , 10.1073/PNAS.95.15.8985
Mercedes E Gorre, Mansoor Mohammed, Katharine Ellwood, Nicholas Hsu, Ron Paquette, P Nagesh Rao, Charles L Sawyers, Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification Science. ,vol. 293, pp. 876- 880 ,(2001) , 10.1126/SCIENCE.1062538
Bruce R Troen, Molecular mechanisms underlying osteoclast formation and activation Experimental Gerontology. ,vol. 38, pp. 605- 614 ,(2003) , 10.1016/S0531-5565(03)00069-X
Marie-Claire Martyré, Henri Magdelenat, Marie-Claude Bryckaert, Christine Laine-Bidron, Fabien Calvo, Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-β in patients with myelofibrosis with myeloid metaplasia British Journal of Haematology. ,vol. 77, pp. 80- 86 ,(1991) , 10.1111/J.1365-2141.1991.TB07952.X